Skip to main content


Log in

Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript



Accumulating evidences indicate that dysregulated microRNAs (miRNA) are involved in cancer tumorigenesis and progression. In the present study, we evaluated the expression of miR-182 in colorectal cancer and adjacent noncancerous tissues and explored its associations with clinicopathological characteristics and prognosis.


Quantitative real-time PCR was used to analyze the expression of miR-182 in 148 pairs of colorectal cancer and adjacent noncancerous tissues. The relationship between miR-182 expression and clinicopathological characteristics in colorectal cancer tissues was estimated using Mann–Whitney U test or Kruskal–Wallis test, as appropriate. We calculated the survival curves and prognostic values of each variable by the Kaplan–Meier method and Cox proportional hazards regression analysis, respectively.


The expression of miR-182 was found up-regulated in colorectal cancer tissues compared with adjacent noncancerous tissues (p < 0.001), and its up-regulation was significantly correlated with large tumor size (p = 0.016), positive regional lymph node metastasis (p = 0.008), and advanced tumor–node–metastasis stage (p = 0.020). Furthermore, Kaplan–Meier analysis demonstrated that high miR-182 expression predicted poor survival (p = 0.001), and Cox proportional hazards risk analysis indicated that miR-182 was an independent prognostic factor for colorectal cancer.


MiR-182 was up-regulated in colorectal cancer tissues and correlated with adverse clinical characteristics and poor prognosis, indicating that miR-182 might be involved in colorectal cancer progression and could be used as a potential prognostic biomarker and therapeutic target in the management of colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365(9454):153–165

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57(1):43–66

    Article  PubMed  Google Scholar 

  3. Woolf SH (2000) The best screening test for colorectal cancer—a personal choice. N Engl J Med 343(22):1641–1643

    Article  PubMed  CAS  Google Scholar 

  4. Goldman E, Fisher JL (2006) Discrepancies in cancer mortality estimates. Arch Med Res 37(4):548–551

    Article  PubMed  Google Scholar 

  5. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866

    Article  PubMed  CAS  Google Scholar 

  6. Waldman SA, Terzic A (2007) Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA 297(17):1923–1925

    Article  PubMed  CAS  Google Scholar 

  7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834–838

    Article  PubMed  CAS  Google Scholar 

  8. Zhou T, Zhang G, Liu Z, Xia S, Tian H (2012) Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorectal Dis. doi:10.1007/s00384-012-1528-1

    Google Scholar 

  9. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, Subramanian S, Wang L, Smyrk TC, Rodrigues CM, Thibodeau SN, Steer CJ (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9:401

    Article  PubMed  Google Scholar 

  10. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58(10):1375–1381

    Article  PubMed  CAS  Google Scholar 

  11. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4):425–436

    Article  PubMed  CAS  Google Scholar 

  12. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ (2012) MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol 228(2):204–215

    Article  PubMed  CAS  Google Scholar 

  13. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E (2009) Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 106(6):1814–1819

    Article  PubMed  CAS  Google Scholar 

  14. Wang J, Li J, Shen J, Wang C, Yang L, Zhang X (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12:227

    Article  PubMed  CAS  Google Scholar 

  15. Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X, Tang H (2012) MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J 279(7):1252–1260

    Article  PubMed  CAS  Google Scholar 

  16. Sun Y, Fang R, Li C, Li L, Li F, Ye X, Chen H (2010) Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 396(2):501–507

    Article  PubMed  CAS  Google Scholar 

  17. Jiang L, Mao P, Song L, Wu J, Huang J, Lin C, Yuan J, Qu L, Cheng SY, Li J (2010) miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177(1):29–38

    Article  PubMed  Google Scholar 

  18. Mei Q, Li X, Meng Y, Wu Z, Guo M, Zhao Y, Fu X, Han W (2012) A facile and specific assay for quantifying microRNA by an optimized RT-qPCR approach. PLoS One 7(10):e46890

    Article  PubMed  CAS  Google Scholar 

  19. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113(1):25–36

    Article  PubMed  CAS  Google Scholar 

  20. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014):226–230

    Article  PubMed  CAS  Google Scholar 

  21. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K (2007) Regulation of the germinal center response by microRNA-155. Science 316(5824):604–608

    Article  PubMed  CAS  Google Scholar 

  22. Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60

    Article  PubMed  Google Scholar 

  23. Zhang J, Xiao Z, Lai D, Sun J, He C, Chu Z, Ye H, Chen S, Wang J (2012) miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer 107(2):352–359

    Article  PubMed  CAS  Google Scholar 

  24. Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y, Du X, Han W (2012) MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting cyclin D1 and Bcl-2. Carcinogenesis 33(1):220–225

    Article  PubMed  CAS  Google Scholar 

  25. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J (2012) MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating oncogene BMI-1. Mol Med. doi:10.2119/molmed.2012.00304

    PubMed  Google Scholar 

  26. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839–843

    Article  PubMed  Google Scholar 

  27. Woods K, Thomson JM, Hammond SM (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282(4):2130–2134

    Article  PubMed  CAS  Google Scholar 

  28. Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J (2006) Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12(7 Pt 1):2014–2024

    Article  PubMed  CAS  Google Scholar 

Download references


This study was supported by the Shandong Province Natural Science Foundation (no. ZR2010H004) and the National Key Clinical Medical Specialties Foundation. We thank Shuo Chen for providing colon cancer cells.

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Chuanxin Wang.

Additional information

Hui Liu and Lutao Du contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, H., Du, L., Wen, Z. et al. Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value. Int J Colorectal Dis 28, 697–703 (2013).

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: